Account
Inquiry
Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for diabetes and weight management research applications. This synthetic peptide demonstrates superior pharmacological activity through its unique dual mechanism of action.
The compound works by simultaneously activating both GIP and GLP-1 receptors, which enhances insulin secretion in a glucose-dependent manner while suppressing glucagon secretion. This dual activity contributes to improved glycemic control and potential weight loss effects, making it valuable for metabolic disorder research.
Our tirzepatide uk price offers exceptional value for research institutions and pharmaceutical developers. The product is supplied as a lyophilized white powder with guaranteed high purity (99.7%) and consistent batch-to-batch quality. Each vial contains precisely measured 10mg quantities for accurate dosing in experimental protocols.
For research purposes, tirzepatide has shown promising results in glucose homeostasis regulation and appetite suppression. The compound's extended half-life compared to native GLP-1 makes it particularly useful for chronic study models requiring sustained receptor activation.
Proper storage is essential for maintaining peptide integrity. The lyophilized powder should be kept at -20°C in a dry environment, protected from light and moisture. When reconstituted, solutions should be used immediately or stored at 2-8°C for short-term use.
This product is intended for laboratory research use only. Not for human consumption or diagnostic use. Researchers should handle all peptides using appropriate safety protocols and personal protective equipment.
